It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes

@inproceedings{Creusot2014ItsTT,
  title={It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes},
  author={R{\'e}mi J Creusot and Nick Giannoukakis and Massimo M. Trucco and Michael J Clare-Salzler and C. Garrison Fathman},
  booktitle={Diabetes},
  year={2014}
}
Type 1 diabetes (T1D) is an autoimmune disease that results from a deficient induction or maintenance of tolerance to islet b-cell antigens, allowing the eventual T-cell–mediated destruction of insulin-producing b-cells within the pancreatic islets (1). Under homeostatic conditions, immune tolerance is established by various subsets of antigen-presenting cells (APCs) with toleranceinducing/maintaining (tolerogenic) functions and reinforced by other cells with suppressor and immunomodulatory… CONTINUE READING
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 27 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 67 REFERENCES

Therapeutic potential of semi-mature dendritic cells for tolerance induction

  • MB Lutz
  • Front Immunol
  • 2012
Highly Influential
16 Excerpts

Similar Papers

Loading similar papers…